United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,024 | -23,651 | -21,046 | -8,859 | -5,678 |
| Depreciation Amortization | 518 | 3,135 | 2,645 | 2,078 | 1,024 |
| Accounts receivable | -425 | -5,504 | -7,519 | -8,922 | -246 |
| Accounts payable and accrued liabilities | -178 | -3,361 | -2,427 | -592 | -3,239 |
| Other Working Capital | 1,606 | -12,340 | -15,276 | -13,747 | -4,080 |
| Other Operating Activity | 1,073 | 19,463 | 21,095 | 14,211 | 4,200 |
| Operating Cash Flow | $-430 | $-22,258 | $-22,528 | $-15,831 | $-8,019 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,767 | -11,218 | N/A | N/A | N/A |
| PPE Investments | -1,058 | -3,580 | -2,643 | -636 | -472 |
| Net Acquisitions | -1,500 | -4,914 | -4,913 | -2,846 | -500 |
| Purchase Of Investment | N/A | -500 | -1,218 | -1,218 | -1,226 |
| Sale Of Investment | 641 | 140,567 | 140,576 | 11,727 | 6,590 |
| Purchase Sale Intangibles | -300 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -300 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-30,984 | $120,355 | $131,802 | $7,027 | $4,392 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -38 | N/A | N/A | N/A |
| Common Stock Issued | 12 | 245 | 206 | 10 | N/A |
| Other Financing Activity | -15 | -22 | -46 | -33 | -20 |
| Financing Cash Flow | $-3 | $185 | $160 | $-23 | $-20 |
| Beginning Cash Position | 122,655 | 24,373 | 24,373 | 24,373 | 24,373 |
| End Cash Position | 91,238 | 122,655 | 133,807 | 15,546 | 20,726 |
| Net Cash Flow | $-31,417 | $98,282 | $109,434 | $-8,827 | $-3,647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -430 | -22,258 | -22,528 | -15,831 | -8,019 |
| Capital Expenditure | -1,061 | -3,581 | -2,644 | -637 | -473 |
| Free Cash Flow | -1,491 | -25,839 | -25,172 | -16,468 | -8,492 |